- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06310174
Study Examining the Effect of a Novel Cannulation Knife on User Satisfaction and Common Central Venous Catheter Insertion Complications (SCAD)
A Pilot Study Examining the Effect of a Novel Cannulation Knife on User Satisfaction and Common Central Venous Catheter Insertion Complications
Study Overview
Status
Conditions
Detailed Description
The primary objective is to assess user satisfaction with a new cannulation knife for central venous catheter (CVC) insertion. Secondary objectives include assessing the frequency of skin incision revisions, frequency of procedures being aborted and restarted, frequency of reverting to the use of the scalpel customarily used to make the incision, frequency of bleeding around the catheter after completion of the procedure, assessment of time to final catheter placement, and the frequency of central line-associated bloodstream infections (CLABSI).
The cannulation knife will be studied in three clinical areas:
- Cardiovascular Operating Room
- Cardiovascular Surgical Intensive Care Unit
- Interventional Cardiology
A prospective cohort of 24 clinicians will be enrolled. Each clinician will be asked to perform a total of five observed cannulations, resulting in a combined 120 observed procedures.
In cases where both the clinician and patient are amenable, a video recording will be taken of the procedure to document the study variables of interest (duration of the procedure, need for revisions, the incidence of bleeding, size of the final incision, etc.) and allow for later review.
All clinicians will be given a survey. This survey is designed to assess the clinicians impression of the device's benefit and the need for 1) revisions of the incision or, 2) aborting the initial attempt. Clinicians will also be timed from procedure start to final catheter placement and will be monitored for incidence of common complications (back bleeding around the catheter, need to revise incision, need to abort/restart procedure) and need to revert to use of a standard scalpel. Although clinicians are the primary focus of this investigation, patients will also be consented to the study and will be monitored for the development of CLABSI post-procedure.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Lisa Fornaresio, PhD
- Phone Number: 443.927.3984
- Email: lisa.fornaresio@jhmi.edu
Study Contact Backup
- Name: Zyriah Robinson
- Phone Number: 443.927.3983
- Email: zyriah.robsinson@jhmi.edu
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Recruiting
- Johns Hopkins Hospital
-
Principal Investigator:
- James Gammie, MD
-
Contact:
- Lisa Fornaresio, PhD
- Phone Number: 443-927-3984
- Email: lisa.fornaresio@jhmi.edu
-
Contact:
- Zyriah Robinson
- Phone Number: 443.927.3983
- Email: zyriah.robinson@jhmi.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
A prospective cohort of 100 clinicians will be enrolled.
The cannulation knife will be studied in three clinical areas:
- Cardiovascular Operating Room
- Cardiovascular Surgical Intensive Care Unit
- Interventional Cardiology
Description
Inclusion Criteria:
- Patient requires a 5 French, 7 French, or 12-14 French central venous catheter.
- Operator responsible for insertion of central venous catheter.
Exclusion Criteria:
- Patient unwilling to consent.
- Operator unwilling to complete the survey.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
User satisfaction with the new cannulation knife for CVC insertion.
Time Frame: Within one (1) hour post-procedure
|
Using a survey developed by the study team, Operators will rate the performance of the cannulation knife in regards to the ease of skin incision, ease of dilator insertion, device safety, and opinion on usage for central venous line (CVL) placement with ongoing cardiopulmonary resuscitation (CPR), using a Likert Scale (scores range from 1: significant benefit to 5: significant hindrance).
The possible overall score ranges from four (4) to twenty (20), with a higher score indicating user dissatisfaction and hindrance.
|
Within one (1) hour post-procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of skin incision revisions.
Time Frame: Within one (1) hour post-procedure
|
Operator will answer: Did you have to revise the incision?
Yes No
|
Within one (1) hour post-procedure
|
Frequency of procedures being aborted and restarted.
Time Frame: Within one (1) hour post-procedure
|
Operator will answer: Did you have to abort the procedure and start over?
Yes No
|
Within one (1) hour post-procedure
|
Frequency of reverting to use of the scalpel normally used to make the incision.
Time Frame: Within one (1) hour post-procedure
|
Did you have to revert to using an #11 blade?
|
Within one (1) hour post-procedure
|
Presence of a clean, dry dressing.
Time Frame: Within thirty-six hours (36) post-procedure
|
Is dressing dry, clean, and intact?
|
Within thirty-six hours (36) post-procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: James Gammie, MD, Johns Hopkins University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB00362883
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Central Venous Catheter Exit Site Infection
-
3MTerminatedCatheter-Related Infections | Central Venous Catheter Exit Site InfectionChina
-
University of Colorado, DenverChildren's Hospital ColoradoRecruitingCentral Venous Catheter Related Bloodstream Infection | Central Venous Catheter Exit Site InfectionUnited States
-
Saglik Bilimleri Universitesi Gulhane Tip FakultesiRecruitingStem Cell Transplant Complications | Central Venous Catheter Exit Site InfectionTurkey
-
E-DA HospitalCompletedPeritoneal Dialysis Catheter Exit Site Infection
-
Hôpital Raymond PoincaréUnknownCatheter Related Infection | Infection of Catheter Exit SiteFrance
-
Singapore General HospitalActive, not recruitingPeritoneal Dialysis Catheter Exit Site InfectionSingapore
-
Singapore General HospitalJohnson & JohnsonCompletedPeritoneal Dialysis Catheter Exit Site InfectionSingapore
-
Fraser HealthSterileCare Inc.; Center for Health Evaluation & Outcome ServicesRecruitingCentral Venous Catheter Thrombosis | Catheter Infection | Catheter Complications | Catheter | Catheter Blockage | Catheter Dysfunction | Central Line-associated Bloodstream Infection (CLABSI) | Central Venous Catheter Related Bloodstream InfectionCanada
-
Istanbul Medeniyet UniversityRecruitingCatheter-Related Infections | Central Venous Catheter Related Bloodstream Infection | Bloodstream Infection Due to Central Venous CatheterTurkey
-
Fudan UniversityShanghai Zhongshan Hospital; Huashan Hospital; Children's Hospital of Fudan University and other collaboratorsRecruitingQuality Improvement | Central Venous Catheter Associated Bloodstream Infection | CLABSI - Central Line Associated Bloodstream Infection | Central Venous Catheter Related Bloodstream Infection | Central Line Infection | CRBSI - Catheter Related Bloodstream Infection | Evidence-based Nursing PracticeChina